UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy

Trends in Cancer, 2020-02, Vol.6 (2), p.86-97

2020

Volltextzugriff (PDF)

Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review

Journal of Drug Delivery, 2013-01, Vol.2013 (2013), p.113-124

2013

Volltextzugriff (PDF)

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

Clinical cancer research, 2004-02, Vol.10 (4), p.1318-1325

2004

Volltextzugriff (PDF)

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10030), p.1837-1846

2016

Volltextzugriff (PDF)

Opening Windows for Thymic Tumors

Journal of thoracic oncology, 2023-02, Vol.18 (2), p.136-138

2023

Volltextzugriff (PDF)

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

BMC cancer, 2018-01, Vol.18 (1), p.106-106, Article 106

2018

Volltextzugriff (PDF)

Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4736-4742

2007

Volltextzugriff (PDF)

Long-term COVID-19 pandemic impact on suicide Thoughts and Behaviors (STB): An interrupted time series analysis in Spain 2-year after pandemic outbreak

Psychiatry research, 2024-09, Vol.339, p.116086, Article 116086

2024

Volltextzugriff (PDF)

Reflections on the Implementation of Low-dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain

Archivos de bronconeumología (English ed.), 2017-10, Vol.53 (10), p.568-573

2017

Volltextzugriff (PDF)

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-01, Vol.17 (1), p.12-18

1999

Volltextzugriff (PDF)

Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel

Future oncology (London, England), 2015-01, Vol.11 (2), p.267-277

2015

Volltextzugriff (PDF)

Recurrence of suicidal thoughts and behaviors during one year of follow-up: An exploratory study

Psychiatry research, 2020-06, Vol.288, p.112988-112988, Article 112988

2020

Volltextzugriff (PDF)

Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC

Journal of thoracic oncology, 2018-05, Vol.13 (5), p.e76-e77

2018

Volltextzugriff (PDF)

Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy

Clinical & translational oncology, 2024-09

2024

Volltextzugriff (PDF)

Bilateral Choroidal Metastases Revealing an Advanced Non-Small Cell Lung Cancer

The Annals of thoracic surgery, 2009-09, Vol.88 (3), p.1013-1015

2009

Volltextzugriff (PDF)

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Cancer medicine (Malden, MA), 2021-09, Vol.10 (17), p.5878-5888

2021

Volltextzugriff (PDF)

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline

Practical Radiation Oncology, 2024-09, Vol.14 (5), p.377-397

2024

Volltextzugriff (PDF)

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

The lancet oncology, 2012-03, Vol.13 (3), p.239-246

2012

Volltextzugriff (PDF)

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

Anticancer research, 2019-03, Vol.39 (3), p.1317-1328

2019

Volltextzugriff (PDF)

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.161-168

2019

Volltextzugriff (PDF)

Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art

Translational lung cancer research, 2015-04, Vol.4 (2), p.191-197

2015

Volltextzugriff (PDF)

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS)

Clinical & translational oncology, 2011-05, Vol.13 (5), p.328-334

2011

Volltextzugriff (PDF)

Efficacy and safety of lurbinectedin (LUR) with irinotecan (IRI) in patients (Pts) with relapsed small cell lung cancer (SCLC): Results from a phase 2 expansion cohort

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8094-8094

2024

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(76)
Humans
(68)
Male
(49)
Female
(47)
Middle Aged
(45)
Aged
(40)
Oncology
(35)
Adult
(34)
Lung Neoplasms - Drug Therapy
(17)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Immunology
(14)
Lung Cancer
(13)
Lung Neoplasms - Pathology
(13)
Treatment Outcome
(13)
Biological And Medical Sciences
(12)
Chemotherapy
(12)
Medical Sciences
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Retrospective Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy

Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

Opening Windows for Thymic Tumors

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901

Long-term COVID-19 pandemic impact on suicide Thoughts and Behaviors (STB): An interrupted time series analysis in Spain 2-year after pandemic outbreak

Reflections on the Implementation of Low-dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel

Recurrence of suicidal thoughts and behaviors during one year of follow-up: An exploratory study

Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC

Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer

Bilateral Choroidal Metastases Revealing an Advanced Non-Small Cell Lung Cancer

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)

Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS)

Efficacy and safety of lurbinectedin (LUR) with irinotecan (IRI) in patients (Pts) with relapsed small cell lung cancer (SCLC): Results from a phase 2 expansion cohort

Suchergebnisse filtern